Clintrex 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
4 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
risvodetinib (IkT-148009) / Inhibikase, Clintrex, ABLi Therapeutics
IkT-148009-201, NCT05424276: A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease

Active, not recruiting
2
120
US
IkT-148009, Placebo
ABLi Therapeutics, Inc.
Parkinson Disease
10/24
06/25
NCT04350177: A Study to Assess Single and Multiple Doses of IkT-148009 in Healthy Elderly Participants and Parkinson's Patients

Completed
1
101
US
IkT-148009, Placebo
ABLi Therapeutics, Inc.
Healthy Elderly, Parkinson Disease
10/22
01/23
NCT06641557: A Phase I Dosing Study of IkT-148009.

Completed
1
6
US
200mg of Ikt-148009
ABLi Therapeutics, Inc.
Healthy
03/23
04/23
NCT06644326: A PK Study of IkT-148009 in Older and Elderly Healthy Subjects

Completed
1
8
US
100mg IkT-148009 Wet, 200 mg Itraconazole, 100mg IkT-148009 Dry, 50mg IkT-148009 Wet
Inhibikase Therapeutics, Inc.
Healthy
08/24
08/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
risvodetinib (IkT-148009) / Inhibikase, Clintrex, ABLi Therapeutics
IkT-148009-201, NCT05424276: A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease

Active, not recruiting
2
120
US
IkT-148009, Placebo
ABLi Therapeutics, Inc.
Parkinson Disease
10/24
06/25
NCT04350177: A Study to Assess Single and Multiple Doses of IkT-148009 in Healthy Elderly Participants and Parkinson's Patients

Completed
1
101
US
IkT-148009, Placebo
ABLi Therapeutics, Inc.
Healthy Elderly, Parkinson Disease
10/22
01/23
NCT06641557: A Phase I Dosing Study of IkT-148009.

Completed
1
6
US
200mg of Ikt-148009
ABLi Therapeutics, Inc.
Healthy
03/23
04/23
NCT06644326: A PK Study of IkT-148009 in Older and Elderly Healthy Subjects

Completed
1
8
US
100mg IkT-148009 Wet, 200 mg Itraconazole, 100mg IkT-148009 Dry, 50mg IkT-148009 Wet
Inhibikase Therapeutics, Inc.
Healthy
08/24
08/24

Download Options